AIM： TO unravel the possible association of malondialdehyde （MDA） and fructosamine in anemic H pylori infected patients and to observe the alteration in MDA and fructosamine levels in these patients after treatment...AIM： TO unravel the possible association of malondialdehyde （MDA） and fructosamine in anemic H pylori infected patients and to observe the alteration in MDA and fructosamine levels in these patients after treatment for one month. METHODS： Fructosamine, MDA and glucose were estimated in 22 anemic H pylori infected patients and 16 healthy controls. Hematological parameters were also evaluated in both the groups using Sysmex-K-100 automated cell counter. The H pylori infected patients were randomly divided into two groups. Hpylori infected patients in Group Ⅰ received both iron supplementation and anti-H pylori therapy, while patients in Group Ⅱ received only iron supplementation. All the biochemical and hematological parameters were estimated after one month of treatment. RESULTS： In anemic H pylori infected patients, while MDA （5.41 ± 2.16 vs 2.26 ± 0.50; P 〈 0.05） and fructosamine （2.64 ± 0.93 vs 1.60 ± 0.35; P 〈 0.05） were significantly increased, iron （32.72 ± 14.93 vs 110.25 ± 26.58; P 〈 0.05）, hemoglobin （6.9 ± 2.6 vs 12.66 ± 0.74; P 〈 0.05） and ferritin （28.82 ± 16.27 vs 140.43 ± 30.72; P 〈 0.05） levels were significantly decreased compared with the controls. With partial correlation analysis, fructosamine was found to have a significant positive correlation with MDA. In Group I, while MDA level decreased significantly （3.11 ± 1.73 vs 5.50 ± 2.46; P 〈 0.05）, there was a significant increase in iron （84.09 ± 29.51 vs 36.09 ± 17.81; P 〈 0.05）, hemoglobin （10.40 ± 1.11 vs 7.42 ± 1.90; P 〈 0.05） and ferritin （116.91 ± 63.34 vs 30.46 ± 17.81; P 〈 0.05） levels after one month. There was no significant change in the levels of fructosamine in group Ⅰ after treatment. Similarly, no significant alterations were noted in the levels of IDA, fructosamine, hemoglobin or ferritin in Group Ⅱ patients after one month of treatment. CONCLUSION： An increased level of fructosamine and MDA was found in anemic H pylori infected patients. Present data supports the premise that lipid peroxides per se do play a role in the glycation of plasma proteins. Furthermore, the findings from this study indicate that treatment for both anemia and H pylori infections is required for lowering the levels of lipid peroxides in these patients.展开更多
文摘AIM： TO unravel the possible association of malondialdehyde （MDA） and fructosamine in anemic H pylori infected patients and to observe the alteration in MDA and fructosamine levels in these patients after treatment for one month. METHODS： Fructosamine, MDA and glucose were estimated in 22 anemic H pylori infected patients and 16 healthy controls. Hematological parameters were also evaluated in both the groups using Sysmex-K-100 automated cell counter. The H pylori infected patients were randomly divided into two groups. Hpylori infected patients in Group Ⅰ received both iron supplementation and anti-H pylori therapy, while patients in Group Ⅱ received only iron supplementation. All the biochemical and hematological parameters were estimated after one month of treatment. RESULTS： In anemic H pylori infected patients, while MDA （5.41 ± 2.16 vs 2.26 ± 0.50; P 〈 0.05） and fructosamine （2.64 ± 0.93 vs 1.60 ± 0.35; P 〈 0.05） were significantly increased, iron （32.72 ± 14.93 vs 110.25 ± 26.58; P 〈 0.05）, hemoglobin （6.9 ± 2.6 vs 12.66 ± 0.74; P 〈 0.05） and ferritin （28.82 ± 16.27 vs 140.43 ± 30.72; P 〈 0.05） levels were significantly decreased compared with the controls. With partial correlation analysis, fructosamine was found to have a significant positive correlation with MDA. In Group I, while MDA level decreased significantly （3.11 ± 1.73 vs 5.50 ± 2.46; P 〈 0.05）, there was a significant increase in iron （84.09 ± 29.51 vs 36.09 ± 17.81; P 〈 0.05）, hemoglobin （10.40 ± 1.11 vs 7.42 ± 1.90; P 〈 0.05） and ferritin （116.91 ± 63.34 vs 30.46 ± 17.81; P 〈 0.05） levels after one month. There was no significant change in the levels of fructosamine in group Ⅰ after treatment. Similarly, no significant alterations were noted in the levels of IDA, fructosamine, hemoglobin or ferritin in Group Ⅱ patients after one month of treatment. CONCLUSION： An increased level of fructosamine and MDA was found in anemic H pylori infected patients. Present data supports the premise that lipid peroxides per se do play a role in the glycation of plasma proteins. Furthermore, the findings from this study indicate that treatment for both anemia and H pylori infections is required for lowering the levels of lipid peroxides in these patients.
